Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India

NCT01108302 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PATH withdrew IRB approval

Conditions

Postpartum Hemorrhage

Interventions

OTHER: Oxytocin in Uniject

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

[object Object]
[object Object]
[object Object]